Related Experiment Video
Updated: Jul 7, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease
1Department of Pediatrics, Weill Medical College of Cornell University, New York, NY 10021, USA. anm2047@med.cornell.edu
Insights
Human parainfluenza virus type 3 causes severe respiratory illness in children. Understanding how the virus binds and fuses with cells offers potential targets for new therapies to prevent infection.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Human parainfluenza viruses (HPIVs) are a significant cause of pediatric respiratory diseases.
- Current prevention and therapeutic options for HPIV infections are limited.
- HPIVs infect cells through a process involving viral surface glycoproteins and membrane fusion.
Purpose of the Study:
- To review the molecular mechanisms of parainfluenza virus type 3 (HPIV3) binding and cell entry.
- To elucidate how the viral receptor-binding molecule triggers the fusion process.
- To identify potential molecular targets for interrupting HPIV infection.
Main Methods:
- Review of existing literature on HPIV3 cell entry.
- Analysis of molecular interactions between viral glycoproteins and cell surface receptors.
- Examination of the triggering mechanism of viral fusion proteins.
Main Results:
- HPIV3 infection involves specific binding to cell surface receptors.
- Viral glycoproteins coordinate to mediate direct fusion with the host cell membrane.
- The receptor-binding molecule plays a critical role in triggering viral fusion protein activity.
- Key steps in binding, triggering, and fusion are understood at the molecular level.
Conclusions:
- Detailed understanding of HPIV3 cell entry provides insights into viral pathogenesis.
- The molecular steps of binding and fusion represent potential targets for antiviral interventions.
- Further research into these molecular mechanisms could lead to effective prevention and therapies for HPIV infections.
Abstract:
Human parainfluenza viruses cause several serious respiratory diseases in children for which there is no effective prevention or therapy. Parainfluenza viruses initiate infection by binding to cell surface receptors and then, via coordinated action of the 2 viral surface glycoproteins, fuse directly with the cell membrane to release the viral replication machinery into the host cell's cytoplasm. During this process, the receptor-binding molecule must trigger the viral fusion protein to mediate fusion and entry of the virus into a cell. This review explores the binding and entry into cells of parainfluenza virus type 3, focusing on how the receptor-binding molecule triggers the fusion process. There are several steps during the process of binding, triggering, and fusion that are now understood at the molecular level, and each of these steps represents potential targets for interrupting infection.
Related Concept Videos
Viral Recombination
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Poliomyelitis
Influenza
Respiratory Syncytial Virus Disease
Inhibitors Of Virion Release

